← Open Payments lookup

MICHELLE STONE: Open Payments

NPI 1093257289 · SUMMIT, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,960 in 119 payments from 32 companies in 2025. Trend: 2023 $1,552 · 2024 $1,451 · 2025 $1,960

Food & beverage: $1,960
CompanyPaymentsAmount
Novo Nordisk Inc22$292
Lilly USA, LLC17$276
Vifor Pharma, Inc.9$140
Travere Therapeutics, Inc.6$103
Xeris Pharmaceuticals, Inc.6$97
Boehringer Ingelheim Pharmaceuticals, Inc.5$85
Bayer Healthcare Pharmaceuticals Inc.4$78
Calliditas Therapeutics US Inc.4$75
Ardelyx, Inc.4$75
Amgen Inc.5$74

Products named: JARDIANCE, Rybelsus, Veltassa, GVOKE HYPOPEN, Ozempic, MOUNJARO, Kerendia, TARPEYO.

Industry payments across NJ — which companies pay providers there.